---
schema_version: "secwatch.filing_event.v1"
accession: "0001553350-26-000093"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2026-06-18T20:30:18+00:00"
generated_at: "2026-06-18T20:35:20.639060+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# TOI stockholders elect all eight director nominees, ratify auditor, approve say-on-pay at 2026 annual meeting

## Summary
- Elected eight directors: Brad Hively, Karen Johnson, Mohit Kaushal, Anne McGeorge, Mark Pacala, Mark Stolper, Kimberly Tzoumakas, Daniel Virnich.
- Ratified BDO USA, P.C. as independent auditor for FY 2026 with 75,098,890 votes for, 37,257 against.
- Say-on-pay approved with 25,280,934 for, 282,655 against, 12,126 abstain.
- Advisory vote on executive compensation frequency: annual preferred with 24,918,766 votes (1-year).

## SEC filing metadata
- accession: 0001553350-26-000093
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2026-06-18T20:30:18+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000155335026000093/0001553350-26-000093-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000155335026000093/toi_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001553350-26-000093
- JSON: https://secwatch.observer/filing/0001553350-26-000093.json
- Plain text: https://secwatch.observer/filing/0001553350-26-000093.txt

## Key facts
- Shareholder Votes
  Oncology Institute, Inc. shareholders approved Approval, on a non-binding, advisory basis, of the preferred frequency of future advisory votes on the compensation of the Company’s named executive officers (the “Say-on-Frequency Proposal”) at the 2026-06-17 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2026-06-17
  source text: The Say-on-Frequency Proposal was approved
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799191/000155335026000093/0001553350-26-000093-index.htm
- Shareholder Votes
  Oncology Institute, Inc. shareholders approved Approval, on a non-binding, advisory basis, of the Company’s named executive officers (the “Say-on-Pay Proposal”) at the 2026-06-17 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-17
  source text: The Say-on-Pay Proposal was approved.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799191/000155335026000093/0001553350-26-000093-index.htm
- Shareholder Votes
  Oncology Institute, Inc. shareholders approved Election of eight directors at the 2026-06-17 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-17
  source text: The Company’s stockholders elected eight directors to serve for the ensuing year and until their successors are elected and qualified, or until their earlier death, resignation or removal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799191/000155335026000093/0001553350-26-000093-index.htm
- Shareholder Votes
  Oncology Institute, Inc. shareholders approved Ratification of the Appointment of Independent Registered Public Accountants at the 2026-06-17 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-17
  source text: The ratification of the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799191/000155335026000093/0001553350-26-000093-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.